BRCA1 and cancer: Our findings reveal that haploinsufficiency in zinc finger 251, resulting in partial knockdown of ZNF251 protein (referred to as ZNF251KD), causes resistance to olaparib in multiple BRCA1-mutated cancer cell lines.